| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $22.0M | -98.2% |
| R&D Expense | $92.3M | +109.9% |
| SG&A Expense | $50.7M | +41.0% |
| Operating Income | -$157.8M | -84.0% |
| Pre-tax Income | -$157.7M | -225.1% |
| Income Tax | $48K | — |
| Net Income | -$157.8M | -225.2% |
| EPS (Basic) | -$0.78 | -212.0% |
| EPS (Diluted) | -$0.78 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $35.7M | -19.6% |
| Short-term Investments | $319.8M | +2.7% |
| Accounts Receivable | $11.5M | +248.3% |
| Current Assets | $390.0M | +4.9% |
| Total Assets | $553.6M | -7.4% |
| Current Liabilities | $37.2M | +84.3% |
| Total Liabilities | $68.6M | +130.3% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$78.8M | -76.3% |
| Capital Expenditures | $13.7M | +46.8% |
| Investing Cash Flow | $68.8M | +122.3% |
| Financing Cash Flow | $1.8M | +60.7% |
| Free Cash Flow | -$92.5M | -71.2% |
| -212.0% |
| Stockholders' Equity |
| $485.0M |
| -14.6% |